The influence of antagonists of poly(ADP-ribose)polymerase on the activity of antirheumatic drugs on the development of adjuvant arthritis in rats and on the induction of tyrosine aminotransferase in the liver of rats.
Kröger
H
H
Deutsches Rheumaforschungszentrum Berlin, Germany.
Dietrich
A
A
Grätz
R
R
Klewer
M
M
Wohlert
H
H
Ehrlich
W
W
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology*; D001549:Benzamides / Q000494:pharmacology*; D002110:Caffeine / Q000031:analogs & derivatives / Q000494:pharmacology*; D004790:Enzyme Induction; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D009536:Niacinamide / Q000494:pharmacology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D051381:Rats; D017208:Rats, Wistar; D014444:Tyrosine Transaminase / Q000096:biosynthesis*
D018501:Antirheumatic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D009536:Niacinamide; D002110:Caffeine; C037689:benzamide; D014444:Tyrosine Transaminase